Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 2/20 | 0.46 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6000248 | 0.83 | TBXAS1 (0.55) | TBXAS1CYP11B1CYP11B2CFTRSLC6A2 | |
| Ammonia Solution, Strong SCHEMBL5999476 | 0.83 | SLC6A2 (0.39) | KCNA5CYP11B1CYP11B2SLC6A2SLC6A4 | |
| SCHEMBL10446411 | 0.82 | CFTR (0.58) | KCNA5TBXAS1CYP11B1CYP11B2CFTR | |
| Ammonia Solution, Strong SCHEMBL5998612 | 0.80 | TBXAS1 (0.43) | TBXAS1CYP11B1CYP11B2CFTRSLC6A2 | |
| Ammonia Solution, Strong SCHEMBL6000004 | 0.80 | CYP19A1 (0.49) | KCNA5TBXAS1CYP11B1CYP11B2CFTR | |
| Ammonia Solution, Strong SCHEMBL5998613 | 0.80 | KCNA5 (0.44) | KCNA5TBXAS1CFTRSLC6A2SLC6A4 | |
| Ammonia Solution, Strong SCHEMBL5999497 | 0.78 | CFTR (0.61) | KCNA5TBXAS1CYP11B1CYP11B2CFTR | |
| SCHEMBL23565933 | 0.78 | TBXAS1 (0.43) | TBXAS1CYP11B1CYP11B2CFTRSLC6A2 | |
| SCHEMBL6733043 | 0.78 | CFTR (0.43) | KCNA5CYP11B1CYP11B2CFTRSLC6A2 | |
| SCHEMBL17069338 | 0.76 | CFTR (0.63) | KCNA5TBXAS1CYP11B1CYP11B2CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | K AND K BIOSCIENCE, INC. (US) | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | SIGMAR1, GRM1, GRIN2C | KCNA5 173/4885TBXAS1 2230/4885CYP11B1 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.